Cancer News and Research

Latest Cancer News and Research

Prostate Robotic System that will improve the diagnosis and treatment of prostate cancer

The Singapore General Hospital and Nanyang Technological University (NTU) have jointly developed a Prostate Robotic System that will improve the diagnosis and treatment of prostrate cancer, the fifth most common cancer in Singaporean men.

21 May 2004

Nicotine remains one of the most addictive drugs ever used

Nicotine-the main ingredient in tobacco products-remains one of the most addictive drugs ever used. Still, nearly 72 million people have used nicotine in the United States, according to the 2002 National Survey on Drug Use and Health, which is administered by the Substance Abuse and Mental Health Services Administration (SAMHSA).

21 May 2004

Are we as crazy as mad cows?

When proteins in our body work properly, we can see, smell, consume and digest food, grow muscle and brain cells. But when these infinitely useful biological building blocks fail, the most pernicious diseases arise. Susan Lindquist has scrutinized the complex origami-like shapes of proteins and come to understand how structural mistakes can lead to a frightening class of neurodegenerative disorders, including “Mad Cow Disease.”

20 May 2004

Tumour suppressor gene family may be key to new colon cancer drugs

In the hunt for new cancer drug targets, scientists from the Johns Hopkins Kimmel Cancer Center and the Howard Hughes Medical Institute have discovered mutations in a family of genes linked to more than a quarter of colon cancers, as well as several other common cancers including breast and lung.

20 May 2004

Scientists believe that the dog genome holds a wealth of information that will benefit human health

Recently completed genetic analysis reveals that half of the more than 300 inherited canine disorders — including a number of cancers — resemble specific diseases of man; many scientists believe that the dog genome holds a wealth of information that will benefit human health.

20 May 2004

Diabetes drug improves metabolic changes associated with HIV combination therapy

Use of an oral antidiabetes medication produced significant improvement in a group of patients with HIV lipodsytrophy, a syndrome involving the redistribution of fat and other metabolic changes in those receiving combination drug therapy for HIV infection.

20 May 2004

FDA finalizes new rule on donor eligibility for human tissues and cells

FDA today published a final rule establishing donor eligibility criteria for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps) to help prevent the transmission of communicable disease when these products are transplanted.

20 May 2004

Protein that appears to play a key role in Alzheimer's disease

A protein that allows human cancer to resist multiple anticancer drugs also appears to play a key role in Alzheimer's disease, according to research conducted at Fox Chase Cancer Center. The protein, active in brain tissue, could be a target for new drugs to treat patients with Alzheimer's.

20 May 2004

Obese women more likely to have pregnancy complications and caesarean sections than women of average weight

The controlled study is one of the largest ever to look at obesity in pregnancy, following more than 16,000 pregnant women at 14 medical centers across the country.

20 May 2004

Antioxidant vitamins A, C and E are unlikely to prevent heart disease and other diseases such as cancer

The study found that individuals who have diets rich in these vitamins are people who are less likely to have ever lived in deprived social circumstances, less likely to have ever smoked, more likely to be physically active and less likely to be obese. It is these factors rather than the vitamins that protect individuals from disease.

20 May 2004

Public health groups strongly support bipartisan FDA tobacco legislation

Our public health organizations strongly support the bipartisan legislation introduced today in both the House and Senate to provide the U.S. Food and Drug Administration (FDA) with effective authority to regulate tobacco products.

20 May 2004

Cell division can be halted in multiple ways, with implications for cancer

Brown University researchers have found that there are multiple independent ways to stop cell division, a phenomenon that prevents the spread of genetic mutation, which can make cells cancerous. Results of this research, along with an accompanying editorial, were published in the current issue of the journal Molecular Cell.

20 May 2004

Scientists have sped up a common jumping gene found in the human genome

Johns Hopkins scientists have transformed a common "jumping gene" found in the human genome into one that moves hundreds of times more often than normal in mouse and human cells.

20 May 2004

Causes of hepatitis and potential therapies that may improve care presented in study

Hepatitis, a potentially serious disease caused by a virus that attacks the liver, is a major problem worldwide. Hepatitis A is generally food-borne, while hepatitis B and C spread primarily through parenteral or sexual routes. Hepatitis B and C can be life-long, potentially deadly chronic infections.

19 May 2004

Studies identify risk factors for colon cancer in women

In new studies presented today at Digestive Disease Week in New Orleans, scientists report that women’s preferences for a female physician may delay or prevent proper colorectal screenings due to a lack of females in the field and diabetes may be a significant risk factor for development of colon cancer.

19 May 2004

Caffeinated beverages may benefit some people who are at high-risk for liver disease

According to new research presented today at Digestive Disease Week, drinking caffeinated beverages may benefit some people who are at high-risk for liver disease. Conversely, a study by researchers from India found that soda drinkers, who represent a huge percentage of the American population, may actually have an increased risk of developing esophageal cancer.

19 May 2004

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation (HCT) and survive can expect full recovery to take 3-5 years, according to a study published in the May 19 issue of The Journal of the American Medical Association (JAMA).

19 May 2004

New study of tumor genetics may help to treat patients with head and neck cancer

Head and neck tumors account for more than 40,000 new cancers annually in the United States. The most common of these is squamous cell carcinoma. Prognosis is based largely on location and size of the tumor, and if the cancer has spread, or metastasized, to lymph nodes and distant sites in the body.

19 May 2004

$First drug approved for hormone refractory prostate cancer that has shown a survival benefit$

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

19 May 2004

FDA approves new drug for bone marrow disease

The Food and Drug Administration (FDA) today announced the approval of Vidaza (azacitidine) injection, the first effective treatment for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.

19 May 2004

Cancer News and Research

Latest Cancer News and Research

Prostate Robotic System that will improve the diagnosis and treatment of prostate cancer

Nicotine remains one of the most addictive drugs ever used

Are we as crazy as mad cows?

Tumour suppressor gene family may be key to new colon cancer drugs

Scientists believe that the dog genome holds a wealth of information that will benefit human health

Diabetes drug improves metabolic changes associated with HIV combination therapy

FDA finalizes new rule on donor eligibility for human tissues and cells

Protein that appears to play a key role in Alzheimer's disease

Obese women more likely to have pregnancy complications and caesarean sections than women of average weight

Antioxidant vitamins A, C and E are unlikely to prevent heart disease and other diseases such as cancer

Public health groups strongly support bipartisan FDA tobacco legislation

Cell division can be halted in multiple ways, with implications for cancer

Scientists have sped up a common jumping gene found in the human genome

Causes of hepatitis and potential therapies that may improve care presented in study

Studies identify risk factors for colon cancer in women

Caffeinated beverages may benefit some people who are at high-risk for liver disease

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

New study of tumor genetics may help to treat patients with head and neck cancer

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

FDA approves new drug for bone marrow disease

Cancer Research - Second Edition eBook

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Newsletters you may be interested in